MERSANA THERAPEUTICS INC. - COMMON STOCK
0.5995
18-February-25 12:07:56
15 minutes delayed
Stocks
+0.0175
+3.01%
Today's range
0.5936 - 0.6200
ISIN
N/A
Source
NASDAQ
-
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
31 Oct 2023 16:30:25 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
31 Oct 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Changes in Leadership
06 Sep 2023 07:00:40 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 16:05:52 By Nasdaq GlobeNewswire
-
27 Jul 2023 07:06:23 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 Jun 2023 07:30:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 Apr 2023 16:05:01 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 Mar 2023 19:10:38 By Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 Feb 2023 08:00:01 By Nasdaq GlobeNewswire